Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study
Authors:
Open Access
- 1 August 2015
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 17 (8) , 542-547
Abstract
Background: ASPIRE In-Home randomized 247 subjects with type 1 diabetes to sensor-augmented pump therapy with or without the Threshold Suspend (TS) feature, which interrupts insulin delivery at a preset sensor glucose value. We studied the effects of TS on nocturnal hypoglycemia (NH) in relation to baseline hemoglobin A1c (A1C) and change in A1C during the study. Materials and Methods: NH event rates and mean area under curve (AUC) of NH events were evaluated at different levels of baseline A1C (8%) and at different levels of changes in A1C (less than −0.3% [decreased], −0.3% to 0.3% [stable], and >0.3% [increased]), in the TS Group compared with the Control Group (sensor-augmented pump only). Results: In the TS Group, 27.9% of the NH events were accompanied by a confirmatory blood glucose value, compared with 39.3% in the Control Group. Among subjects with baseline A1C levels of P =0.001 and P =0.004, respectively). Among subjects with decreased or stable A1C levels, those in the TS Group had significantly lower NH event rates, and the events had lower AUCs ( P ≤0.001 for each). Among subjects with increased A1C levels, those in the TS Group had NH events with significantly lower AUCs ( P <0.001). Conclusions: Use of the TS feature was associated with decreases in the rate and severity (as measured by AUC) of NH events in many subjects, including those with low baseline A1C levels and those whose A1C values decreased during the study period. Use of the TS feature can help protect against hypoglycemia in those wishing to intensify diabetes management to achieve target glucose levels.Keywords
This publication has 22 references indexed in Scilit:
- Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE StudyDiabetes Technology & Therapeutics, 2012
- Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump TherapyDiabetes Technology & Therapeutics, 2011
- Insulin Pump Therapy With Automated Insulin Suspension in Response to HypoglycemiaDiabetes Care, 2011
- Perceived family burden and emotional distress: similarities and differences between mothers and fathers of children with type 1 diabetes in a population-based studyPediatric Diabetes, 2011
- Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 DiabetesDiabetes Care, 2010
- The Barrier of Hypoglycemia in DiabetesDiabetes, 2008
- Duration of Nocturnal Hypoglycemia Before SeizuresDiabetes Care, 2008
- Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetesPediatric Diabetes, 2007
- Awakening and Counterregulatory Response to Hypoglycemia During Early and Late SleepDiabetes, 2007
- Epidemiology of severe hypoglycemia in the diabetes control and complications trialThe American Journal of Medicine, 1991